BDBM676752 2-[(11R,15S)-13,16-dioxa-2,4,10-triazatetracyclo[7.7.0.0{}{3,7}.0{}{11,15}]hexadeca-1(9),2,5,7-tetraen-10-yl]-4-{2-[(2S)-2-(4-fluoro-2-isopropylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl}-N-{3-nitro-4-[(oxan-4-ylmethyl)amino]benzenesulfonyl}benzamide::US20240166646, Example 60

SMILES CC(C)c1cc(F)ccc1[C@@H]1CCCN1C1CC2(C1)CCN(CC2)c1ccc(C(=O)NS(=O)(=O)c2ccc(NCC3CCOCC3)c(c2)[N+]([O-])=O)c(c1)N1[C@@H]2COC[C@H]2Oc2nc3[nH]ccc3cc12

InChI Key InChIKey=DQBCFPLBUJLMCZ-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 676752   

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandPNGBDBM676752(2-[(11R,15S)-13,16-dioxa-2,4,10-triazatetracyclo[7...)
Affinity DataIC50: 0.341nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2024
Entry Details
Go to US Patent